{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:44:51Z","timestamp":1782913491216,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00509487"],"award-info":[{"award-number":["RS-2024-00509487"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00340161"],"award-info":[{"award-number":["RS-2024-00340161"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00442483"],"award-info":[{"award-number":["RS-2024-00442483"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Inducible T cell costimulator (ICOS) signalling is essential for follicular helper T (Tfh) cell activation and has emerged as a therapeutic target in B cell-dependent autoimmune diseases such as systemic lupus erythematosus (SLE). However, its dual role in supporting both Foxp3\n                    <jats:sup>+<\/jats:sup>\n                    regulatory T (Treg) cells and Tfh cell responses complicates therapeutic interventions. Here, we demonstrate that disruption of ICOS signalling in\n                    <jats:italic>Sanroque<\/jats:italic>\n                    mice impairs Treg cell maintenance, unleashing pathogenic T cell responses. In ICOS ligand-deficient\n                    <jats:italic>Sanroque<\/jats:italic>\n                    mice, defective ICOS signalling disrupts canonical Tfh cell-dependent germinal centre (GC) responses but fails to prevent autoantibody production and reverse SLE-like symptoms. Notably, Treg cell reduction in ICOS ligand-deficient\n                    <jats:italic>Sanroque<\/jats:italic>\n                    mice is associated with augmentation of self-reactive neuropilin-1 (Nrp-1)\n                    <jats:sup>hi<\/jats:sup>\n                    CD4\n                    <jats:sup>+<\/jats:sup>\n                    conventional T (Tconv) cells. Mechanistically, Nrp-1\n                    <jats:sup>hi<\/jats:sup>\n                    CD4\n                    <jats:sup>+<\/jats:sup>\n                    Tconv cells effectively produce IFN-\u03b3 and outcompete Treg cells for dendritic cell engagement. Nrp-1\n                    <jats:sup>hi<\/jats:sup>\n                    CD4\n                    <jats:sup>+<\/jats:sup>\n                    Tconv cells acquire PD-1\n                    <jats:sup>hi<\/jats:sup>\n                    CXCR5\n                    <jats:sup>\u2212<\/jats:sup>\n                    peripheral helper T (Tph) cell phenotype, and drive non-GC B cell responses by promoting the induction of age-associated B cells through contact-dependent mechanisms in the absence of Treg cells. Our findings highlight that ICOS signalling orchestrates GC and non-GC B cell responses in SLE via impaired Treg cell maintenance, and also underscore potential risks in therapeutic strategies targeting ICOS signalling for SLE, as it could inadvertently promote T cell-mediated inflammation and non-GC B cell responses through the induction of age-associated B cells.\n                  <\/jats:p>","DOI":"10.1038\/s12276-026-01756-6","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:36:13Z","timestamp":1781076973000},"page":"1971-1986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Defective inducible T cell costimulator signalling drives neuropilin-1hi CD4+ T cell-mediated non-germinal centre B cell activation via impaired regulatory T cell maintenance in a lupus model"],"prefix":"10.1038","volume":"58","author":[{"given":"Sumin","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunju","family":"O","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesung","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9718-726X","authenticated-orcid":false,"given":"Sung-Wook","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6250-1068","authenticated-orcid":false,"given":"Kwang Soon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"1756_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/art.40396","volume":"70","author":"S Karrar","year":"2018","unstructured":"Karrar, S. & Cunninghame Graham, D. S. Abnormal B cell development in systemic lupus erythematosus: what the genetics tell us. Arthritis Rheumatol. 70, 496\u2013507 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"1756_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102976","volume":"134","author":"X Wei","year":"2023","unstructured":"Wei, X. & Niu, X. T follicular helper cells in autoimmune diseases. J. Autoimmun. 134, 102976 (2023).","journal-title":"J. Autoimmun."},{"key":"1756_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/imr.12741","volume":"288","author":"SA Jenks","year":"2019","unstructured":"Jenks, S. A., Cashman, K. S., Woodruff, M. C., Lee, F. E. & Sanz, I. Extrafollicular responses in humans and SLE. Immunol. Rev. 288, 136\u2013148 (2019).","journal-title":"Immunol. Rev."},{"key":"1756_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature03555","volume":"435","author":"CG Vinuesa","year":"2005","unstructured":"Vinuesa, C. G. et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435, 452\u2013458 (2005).","journal-title":"Nature"},{"key":"1756_CR5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.immuni.2013.03.007","volume":"38","author":"SA Bertino","year":"2013","unstructured":"Bertino, S. A. & Craft, J. Roquin paralogs add a new dimension to ICOS regulation. Immunity 38, 624\u2013626 (2013).","journal-title":"Immunity"},{"key":"1756_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.immuni.2012.10.010","volume":"37","author":"SK Lee","year":"2012","unstructured":"Lee, S. K. et al. Interferon-gamma excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity 37, 880\u2013892 (2012).","journal-title":"Immunity"},{"key":"1756_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.immuni.2012.12.004","volume":"38","author":"KU Vogel","year":"2013","unstructured":"Vogel, K. U. et al. Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation. Immunity 38, 655\u2013668 (2013).","journal-title":"Immunity"},{"key":"1756_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.immuni.2013.01.011","volume":"38","author":"A Pratama","year":"2013","unstructured":"Pratama, A. et al. Roquin-2 shares functions with its paralog Roquin-1 in the repression of mRNAs controlling T follicular helper cells and systemic inflammation. Immunity 38, 669\u2013680 (2013).","journal-title":"Immunity"},{"key":"1756_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nature06253","volume":"450","author":"D Yu","year":"2007","unstructured":"Yu, D. et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450, 299\u2013303 (2007).","journal-title":"Nature"},{"key":"1756_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.4049\/jimmunol.1102432","volume":"189","author":"PP Chang","year":"2012","unstructured":"Chang, P. P. et al. Breakdown in repression of IFN-\u03b3 mRNA leads to accumulation of self-reactive effector CD8+ T cells. J. Immunol. 189, 701\u2013710 (2012).","journal-title":"J. Immunol."},{"key":"1756_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.20081886","volume":"206","author":"MA Linterman","year":"2009","unstructured":"Linterman, M. A. et al. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206, 561\u2013576 (2009).","journal-title":"J. Exp. Med."},{"key":"1756_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4110\/in.2016.16.4.219","volume":"16","author":"YH Jeon","year":"2016","unstructured":"Jeon, Y. H. & Choi, Y. S. Follicular helper T (Tfh) cells in autoimmune diseases and allograft rejection. Immune Netw. 16, 219\u2013232 (2016).","journal-title":"Immune Netw."},{"key":"1756_CR13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.immuni.2011.03.023","volume":"34","author":"YS Choi","year":"2011","unstructured":"Choi, Y. S. et al. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 34, 932\u2013946 (2011).","journal-title":"Immunity"},{"key":"1756_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","volume":"41","author":"S Crotty","year":"2014","unstructured":"Crotty, S. T follicular helper cell differentiation, function, and roles in disease. Immunity 41, 529\u2013542 (2014).","journal-title":"Immunity"},{"key":"1756_CR15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.immuni.2008.03.018","volume":"28","author":"T Ito","year":"2008","unstructured":"Ito, T. et al. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28, 870\u2013880 (2008).","journal-title":"Immunity"},{"key":"1756_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaci.2010.05.022","volume":"126","author":"M Vocanson","year":"2010","unstructured":"Vocanson, M. et al. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17\/TH1 and regulatory T cells. J. Allergy Clin. Immunol. 126, 280\u2013289 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1756_CR17","doi-asserted-by":"crossref","unstructured":"Dominguez-Villar, M. & Hafler, D. A. Regulatory T cells in autoimmune disease. 19, 665\u2013673 (2018).","DOI":"10.1038\/s41590-018-0120-4"},{"key":"1756_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jaci.2016.06.003","volume":"138","author":"M Noval Rivas","year":"2016","unstructured":"Noval Rivas, M. & Chatila, T. A. Regulatory T cells in allergic diseases. J. Allergy Clin. Immunol. 138, 639\u2013652 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1756_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jaut.2009.11.016","volume":"34","author":"BD Hondowicz","year":"2010","unstructured":"Hondowicz, B. D., Batheja, A. O., Metzgar, M. H., Caton, A. J. & Erikson, J. ICOS expression by effector T cells influences the ability of regulatory T cells to inhibit anti-chromatin B cell responses in recipient mice. J. Autoimmun. 34, 460\u2013468 (2010).","journal-title":"J. Autoimmun."},{"key":"1756_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/eji.201344280","volume":"45","author":"K Ohl","year":"2015","unstructured":"Ohl, K. & Tenbrock, K. Regulatory T cells in systemic lupus erythematosus. Eur. J. Immunol. 45, 344\u2013355 (2015).","journal-title":"Eur. J. Immunol."},{"key":"1756_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00159","volume":"10","author":"W Li","year":"2019","unstructured":"Li, W., Deng, C., Yang, H. & Wang, G. The regulatory T cell in active systemic lupus erythematosus patients: a systemic review and meta-analysis. Front. Immunol. 10, 159 (2019).","journal-title":"Front. Immunol."},{"key":"1756_CR22","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1172\/JCI91250","volume":"127","author":"K Rubtsova","year":"2017","unstructured":"Rubtsova, K. et al. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J. Clin. Invest. 127, 1392\u20131404 (2017).","journal-title":"J. Clin. Invest."},{"key":"1756_CR23","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1182\/blood-2011-01-330530","volume":"118","author":"Y Hao","year":"2011","unstructured":"Hao, Y., O\u2019Neill, P., Naradikian, M. S., Scholz, J. L. & Cancro, M. P. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118, 1294\u20131304 (2011).","journal-title":"Blood"},{"key":"1756_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25102-8","volume":"12","author":"E Ricker","year":"2021","unstructured":"Ricker, E. et al. Altered function and differentiation of age-associated B cells contribute to the female bias in lupus mice. Nat. Commun. 12, 4813 (2021).","journal-title":"Nat. Commun."},{"key":"1756_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/imr.13069","volume":"307","author":"KE Marks","year":"2022","unstructured":"Marks, K. E. & Rao, D. A. T peripheral helper cells in autoimmune diseases. Immunol Rev 307, 191\u2013202 (2022).","journal-title":"Immunol Rev"},{"key":"1756_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130062","volume":"4","author":"AV Bocharnikov","year":"2019","unstructured":"Bocharnikov, A. V. et al. PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. JCI Insight 4, e130062, https:\/\/doi.org\/10.1172\/jci.insight.130062 (2019).","journal-title":"JCI Insight"},{"key":"1756_CR27","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202215864","volume":"14","author":"BJ Raveney","year":"2022","unstructured":"Raveney, B. J. et al. Neuropilin-1 (NRP1) expression distinguishes self-reactive helper T cells in systemic autoimmune disease. EMBO Mol. Med. 14, e15864 (2022).","journal-title":"EMBO Mol. Med."},{"key":"1756_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/eji.200324799","volume":"34","author":"D Bruder","year":"2004","unstructured":"Bruder, D. et al. Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol. 34, 623\u2013630 (2004).","journal-title":"Eur. J. Immunol."},{"key":"1756_CR29","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1084\/jem.20120914","volume":"209","author":"JM Weiss","year":"2012","unstructured":"Weiss, J. M. et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 209, 1723\u20131742 (2012).","journal-title":"J. Exp. Med."},{"key":"1756_CR30","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.aac5560","volume":"351","author":"KS Kim","year":"2016","unstructured":"Kim, K. S. et al. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science 351, 858\u2013863 (2016).","journal-title":"Science"},{"key":"1756_CR31","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1126\/science.1191996","volume":"329","author":"YP Rubtsov","year":"2010","unstructured":"Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667\u20131671 (2010).","journal-title":"Science"},{"key":"1756_CR32","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/eji.200839196","volume":"39","author":"JH Duarte","year":"2009","unstructured":"Duarte, J. H., Zelenay, S., Bergman, M. L., Martins, A. C. & Demengeot, J. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur. J. Immunol. 39, 948\u2013955 (2009).","journal-title":"Eur. J. Immunol."},{"key":"1756_CR33","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1053\/j.gastro.2010.12.002","volume":"140","author":"Z Hovhannisyan","year":"2011","unstructured":"Hovhannisyan, Z., Treatman, J., Littman, D. R. & Mayer, L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 140, 957\u2013965 (2011).","journal-title":"Gastroenterology"},{"key":"1756_CR34","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ni.3540","volume":"17","author":"T Chinen","year":"2016","unstructured":"Chinen, T. et al. An essential role for the IL-2 receptor in Treg cell function. Nat. Immunol. 17, 1322\u20131333 (2016).","journal-title":"Nat. Immunol."},{"key":"1756_CR35","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.celrep.2018.10.002","volume":"25","author":"MY Fan","year":"2018","unstructured":"Fan, M. Y. et al. Differential roles of IL-2 signaling in developing versus mature Tregs. Cell Rep. 25, 1204\u20131213.e4 (2018).","journal-title":"Cell Rep."},{"key":"1756_CR36","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4049\/jimmunol.141.3.849","volume":"141","author":"X Paliard","year":"1988","unstructured":"Paliard, X. et al. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. J. Immunol. 141, 849\u2013855 (1988).","journal-title":"J. Immunol."},{"key":"1756_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","volume":"38","author":"W Liao","year":"2013","unstructured":"Liao, W., Lin, J. X. & Leonard, W. J. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13\u201325 (2013).","journal-title":"Immunity"},{"key":"1756_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02104","volume":"11","author":"DY Li","year":"2020","unstructured":"Li, D. Y. & Xiong, X. Z. ICOS+ Tregs: a functional subset of Tregs in immune diseases. Front. Immunol. 11, 2104 (2020).","journal-title":"Front. Immunol."},{"key":"1756_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0927-9","volume":"9","author":"L Yu","year":"2018","unstructured":"Yu, L. et al. CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production. Cell Death Dis. 9, 905 (2018).","journal-title":"Cell Death Dis."},{"key":"1756_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.immuni.2022.01.013","volume":"55","author":"A Biram","year":"2022","unstructured":"Biram, A. et al. Bacterial infection disrupts established germinal center reactions through monocyte recruitment and impaired metabolic adaptation. Immunity 55, 442\u2013458.e8 (2022).","journal-title":"Immunity"},{"key":"1756_CR41","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","volume":"118","author":"AV Rubtsov","year":"2011","unstructured":"Rubtsov, A. V. et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood 118, 1305\u20131315 (2011).","journal-title":"Blood"},{"key":"1756_CR42","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.4049\/jimmunol.1600522","volume":"197","author":"MS Naradikian","year":"2016","unstructured":"Naradikian, M. S. et al. Cutting edge: IL-4, IL-21, and IFN-\u03b3 interact to govern T-bet and CD11c expression in TLR-activated B cells. J. Immunol. 197, 1023\u20131028 (2016).","journal-title":"J. Immunol."},{"key":"1756_CR43","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.4049\/jimmunol.1501209","volume":"195","author":"K Rubtsova","year":"2015","unstructured":"Rubtsova, K., Rubtsov, A. V., Cancro, M. P. & Marrack, P. Age-associated B cells: a T-bet-dependent effector with roles in protective and pathogenic immunity. J Immunol 195, 1933\u20131937 (2015).","journal-title":"J Immunol"},{"key":"1756_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.immuni.2008.01.012","volume":"28","author":"M Sarris","year":"2008","unstructured":"Sarris, M., Andersen, K. G., Randow, F., Mayr, L. & Betz, A. G. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28, 402\u2013413 (2008).","journal-title":"Immunity"},{"key":"1756_CR45","doi-asserted-by":"publisher","first-page":"10113","DOI":"10.1073\/pnas.0711106105","volume":"105","author":"Y Onishi","year":"2008","unstructured":"Onishi, Y., Fehervari, Z., Yamaguchi, T. & Sakaguchi, S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl Acad. Sci. USA 105, 10113\u201310118 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1756_CR46","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.4049\/jimmunol.181.10.6934","volume":"181","author":"R Sharma","year":"2008","unstructured":"Sharma, R., Ju, A. C., Kung, J. T., Fu, S. M. & Ju, S. T. Rapid and selective expansion of nonclonotypic T cells in regulatory T cell-deficient, foreign antigen-specific TCR-transgenic scurfy mice: antigen-dependent expansion and TCR analysis. J. Immunol. 181, 6934\u20136941 (2008).","journal-title":"J. Immunol."},{"key":"1756_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature20810","volume":"542","author":"DA Rao","year":"2017","unstructured":"Rao, D. A. et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature 542, 110\u2013114 (2017).","journal-title":"Nature"},{"key":"1756_CR48","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/eji.201545760","volume":"46","author":"P Blanco","year":"2016","unstructured":"Blanco, P., Ueno, H. & Schmitt, N. T follicular helper (Tfh) cells in lupus: activation and involvement in SLE pathogenesis. Eur. J. Immunol. 46, 281\u2013290 (2016).","journal-title":"Eur. J. Immunol."},{"key":"1756_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00303","volume":"7","author":"LM Wise","year":"2020","unstructured":"Wise, L. M. & Stohl, W. Belimumab and rituximab in systemic lupus erythematosus: a tale of two B cell-targeting agents. Front. Med. 7, 303 (2020).","journal-title":"Front. Med."},{"key":"1756_CR50","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","volume":"377","author":"SV Navarra","year":"2011","unstructured":"Navarra, S. V. et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377, 721\u2013731 (2011).","journal-title":"Lancet"},{"key":"1756_CR51","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/art.40479","volume":"70","author":"LE Cheng","year":"2018","unstructured":"Cheng, L. E. et al. Brief report: a randomized, double-blind, parallel-group, placebo-controlled, multiple-dose study to evaluate AMG 557 in patients with systemic lupus erythematosus and active lupus arthritis. Arthritis Rheumatol. 70, 1071\u20131076 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"1756_CR52","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.immuni.2020.11.006","volume":"53","author":"RA Elsner","year":"2020","unstructured":"Elsner, R. A. & Shlomchik, M. J. Germinal center and extrafollicular B cell responses in vaccination, immunity, and autoimmunity. Immunity 53, 1136\u20131150 (2020).","journal-title":"Immunity"},{"key":"1756_CR53","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1084\/jem.20062567","volume":"204","author":"JR Groom","year":"2007","unstructured":"Groom, J. R. et al. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J. Exp. Med. 204, 1959\u20131971 (2007).","journal-title":"J. Exp. Med."},{"key":"1756_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1021370","volume":"13","author":"LF Voss","year":"2022","unstructured":"Voss, L. F. et al. The extrafollicular response is sufficient to drive initiation of autoimmunity and early disease hallmarks of lupus. Front. Immunol. 13, 1021370 (2022).","journal-title":"Front. Immunol."},{"key":"1756_CR55","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.immuni.2022.01.002","volume":"55","author":"W Song","year":"2022","unstructured":"Song, W. et al. Development of Tbet- and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers. Immunity 55, 290\u2013307.e5 (2022).","journal-title":"Immunity"},{"key":"1756_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030639","volume":"20","author":"S Niland","year":"2019","unstructured":"Niland, S. & Eble, J. A. Neuropilins in the context of tumor vasculature. Int. J. Mol. Sci. 20, 639. https:\/\/doi.org\/10.3390\/ijms20030639 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1756_CR57","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.immuni.2016.09.018","volume":"45","author":"AP Meli","year":"2016","unstructured":"Meli, A. P. et al. The integrin LFA-1 controls T follicular helper cell generation and maintenance. Immunity 45, 831\u2013846 (2016).","journal-title":"Immunity"},{"key":"1756_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1272","volume":"2","author":"T Sekiya","year":"2011","unstructured":"Sekiya, T. et al. The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells. Nat Commun 2, 269 (2011).","journal-title":"Nat Commun"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01756-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01756-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01756-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:48:29Z","timestamp":1782910109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01756-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":58,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1756"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01756-6","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}